In conclusion, the evidence we report in our study supports an association between NLRP3 Q703K and the risk of autoinflammatory syndromes, as indicated by the significantly increased prevalence of this variant in our PFAPA, CAPS and uAID populations. The gene discussed is NLRP3; the disease is autoinflammatory syndrome.